Sirona is a biotechnology company with an innovative platform technology. The platform allows development of safer, more effective cosmetics and pharmaceuticals
Big News! Sirona Biochem’s revolutionary anti-aging compound, TFC-1326, is turning heads in the skincare industry. Featured in Stonegate Healthcare’s latest report.
Full new release here: https://t.co/nmw5K7KBcz
#AntiAging#SkincareInnovation#SironaBiochem
Breakthroughs in carbohydrate-based #technologies are attracting significant attention. Companies specializing in #glycobiology are innovating to meet the demand for safe and effective medical treatments and cosmetic products. @SironaBiochem#biotech https://t.co/wu1PkAltEo
TFC-1326 is the new 'Gold Standard' in anti-aging, outperforming retinoids the current benchmark in major categories. See how TFC-1326 compares to retinoid clinical trials below.
Exciting things are coming! Stay updated by subscribing to our newsletter.
#skincare #biotech #Innovation
Breaking News! Sirona Biochem’s new study, published in the 'Journal of Cosmetic Dermatology', showcases TFC-1326's successful human trial results for TFC-1326!
A true breakthrough for Sirona and in anti-aging science—this is innovation at its best!
News Release: https://t.co/4BZm73MORe
#Clinicaltrial #AntiAging #Skincare #Biotech
Be the first to know! Stay ahead with Sirona Biochem’s latest breakthroughs and updates. Subscribe to our newsletter and visit our website for exciting news coming your way!
https://t.co/WZTw5GD7qO
#Biotech#Innovation#SironaBiochem#SkinCare
The Potential Applications of TFC-1326: As Sirona advances commercialization, we’re exploring its versatile applications in high-demand skincare products across North America, South Korea, and Europe. #Innovation#AntiAging#skincare#Biotech
Sirona Biochem is exploring expansion of its anti-aging compound TFC-1326 into South Korea, driven by strong interest post-GREDECO study. This move boosts market reach, opens doors for Korean partnerships, and fuels sustainable growth. #Skincare#AntiAging#SironaBiochem
Stonegate Capital Partners has initiated coverage on Sirona Biochem (TSX-V: SBM), highlighting our innovative anti-aging compound GlycoProteMim™ and our path to profitability in 2025.
Read the full Initiation of Coverage Report: https://t.co/TWEMajyw7h
#Stonegatehealthcare #Biotech #AntiAging #GlycoProteMim #SironaBiochem #Investing #skincare
Learn more about how our breakthrough ingredient stands out among the other top treatments in the $12.5 billion anti-aging market.
Download Stonegate Healthcare’s Comprehensive Research Report - https://t.co/f380T0ZjaT
#AntiAging#SkincareInnovation#GlycoProteMim #StonegateHealthcare #SkinCareScience #BeautyTech #AntiAgingTreatments #HealthySkin #BioTech #YouthfulSkin
With Stonegate Healthcare's support, Howard Vericco is ready to dive into discussions at #BIO2024 on the future of biotech and the crucial role of Sirona Biochem's breakthrough anti-aging active ingredient, GlycoProtemim.
Learn More About GlycoProtemim - https://t.co/gQDCFdlIp7
#SironaBiochem #GlycoProteMim #Stonegate #Antiaging #Biotech #Cosmetics
Sirona Biochem CEO, Howard Verrico, will be attending #BIO2024, the largest biotech event of the year, in San Diego, California. Stay tuned for updates on his meetings and insights from the conference!
About Bio 2024 - https://t.co/lldAXBDu3g
#Sironabiochem #BioInternationalConvention #Biotech #Glycoprotemim
We are pleased to provide major updates ranging from our latest AGM to the closure of our financing round and the upcoming launch of our GlycoProteMim™ product line.
Read our full press release: https://t.co/0vsw5OdVRo
#SironaBiochem#tfchem#Biotechnology#strategicupdate #corporateupdate #ScienceInnovation #Pharmaceuticals #glycoprotemim
Sirona Biochem was in attendance at the recent PCHI Shanghai 2024 trade fair. Board member Jason Tian was at the fair to showcase our cutting-edge GlycoProteMim™ technology and open dialogue for international partnerships. #SironaBiochem#PCHI2024#SkincareInnovation